studies that needed to run aggressively so the pharmaceutical company could file their New Drug Application (NDA) by the targeted submission date. Medpace’s therapeutically focused, specialized diabetes project teams were quickly mobilized to start the trials simultaneously. The Medpace teams initiated, coordinated, an oversaw all trial activities from project start-up to project completion, tracking metrics and providing a full range of services to the Sponsor.

 

Publications from Medpace